A Comprehensive Cheminformatics Analysis of Structural Features Affecting the Binding Activity of Fullerene Derivatives
暂无分享,去创建一个
Natalja Fjodorova | Marjana Novič | Bakhtiyor Rasulev | Katja Venko | M. Novič | B. Rasulev | N. Fjodorova | K. Venko
[1] Tudor I. Oprea,et al. Property distribution of drug-related chemical databases* , 2000, J. Comput. Aided Mol. Des..
[2] Paola Gramatica,et al. Principles of QSAR models validation: internal and external , 2007 .
[3] M. Prato,et al. Anti-HIV properties of cationic fullerene derivatives. , 2005, Bioorganic & medicinal chemistry letters.
[4] Serdar Durdagi,et al. 3D QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies of fullerene-based HIV-1 PR inhibitors. , 2008, Bioorganic & medicinal chemistry letters.
[5] Andrew P. Worth,et al. The Role of Qsar Methodology in the Regulatory Assessment of Chemicals , 2010 .
[6] T. Puzyn,et al. Toward the development of "nano-QSARs": advances and challenges. , 2009, Small.
[7] G. Lalwani,et al. MULTIFUNCTIONAL FULLERENE- AND METALLOFULLERENE-BASED NANOBIOMATERIALS , 2013 .
[8] Paola Gramatica,et al. The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models , 2003 .
[9] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[10] D. Lyon,et al. Antibacterial activity of fullerene water suspensions: effects of preparation method and particle size. , 2006, Environmental science & technology.
[11] Jure Zupan,et al. Study of structure–toxicity relationship by a counterpropagation neural network , 1999 .
[12] Thomas Sander,et al. DataWarrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis , 2015, J. Chem. Inf. Model..
[13] A. Djordjevic,et al. Review of synthesis and antioxidant potential of fullerenol nanoparticles , 2015 .
[14] Norman S. Allen,et al. Radical scavenging efficiency of different fullerenes C60–C70 and fullerene soot , 2009 .
[15] T. Ritchie,et al. Physicochemical descriptors of aromatic character and their use in drug discovery. , 2014, Journal of medicinal chemistry.
[16] Marjan Vračko,et al. Verification of the geological origin of bottled mineral water using artificial neural networks , 2010 .
[17] J. James,et al. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[18] T. Nagano,et al. Inhibition of E. coli growth by fullerene derivatives and inhibition mechanism. , 1999, Bioorganic & medicinal chemistry letters.
[19] M. Tzirakis,et al. Radical reactions of fullerenes: from synthetic organic chemistry to materials science and biology. , 2013, Chemical reviews.
[20] Jerzy Leszczynski,et al. Inhibitors or toxins? Large library target-specific screening of fullerene-based nanoparticles for drug design purpose. , 2017, Nanoscale.
[21] Delina Y Lyon,et al. Antibacterial activity of fullerene water suspensions: effects of preparation method and particle size. , 2006, Environmental science & technology.
[22] M. Moore,et al. Do nanoparticles present ecotoxicological risks for the health of the aquatic environment? , 2006, Environment international.
[23] B. Rasulev,et al. Aconitum and Delphinium alkaloids "Drug-likeness" descriptors related to toxic mode of action. , 2008, Environmental toxicology and pharmacology.
[24] T. Ritchie,et al. The impact of aromatic ring count on compound developability--are too many aromatic rings a liability in drug design? , 2009, Drug discovery today.
[25] L. Echegoyen,et al. Fullerenes in Biology and Medicine. , 2017, Journal of materials chemistry. B.
[26] T. Keller,et al. A practical view of 'druggability'. , 2006, Current opinion in chemical biology.
[27] Robert Hettich,et al. Fullerenes from the Geological Environment , 1992, Science.
[28] Tudor I. Oprea,et al. Understanding drug‐likeness , 2011 .
[29] M. Gong,et al. Superparamagnetic core/shell GoldMag nanoparticles: size-, concentration- and time-dependent cellular nanotoxicity on human umbilical vein endothelial cells and the suitable conditions for magnetic resonance imaging , 2015, Journal of Nanobiotechnology.
[30] Chunru Wang,et al. Gd@C82-(ethylenediamine)8 Nanoparticle: A New High-Efficiency Water-Soluble ROS Scavenger. , 2016, ACS applied materials & interfaces.
[31] K. Kuča,et al. Fullerenol nanoparticles prevents doxorubicin-induced acute hepatotoxicity in rats. , 2017, Experimental and molecular pathology.
[32] S. Ramakrishna,et al. Recent advances in nanomaterials for water protection and monitoring. , 2017, Chemical Society reviews.
[33] Ayawei Nimibofa,et al. Fullerenes: Synthesis and Applications , 2018, Journal of Materials Science Research.
[34] K. Ausman,et al. C60 in water: nanocrystal formation and microbial response. , 2005, Environmental science & technology.
[35] C. Humblet,et al. Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.
[36] Emilio Benfenati,et al. Modeling Toxicity by Using Supervised Kohonen Neural Networks , 2003, J. Chem. Inf. Comput. Sci..
[37] Nancy G Doerrer,et al. Human and environmental health challenges for the next decade (2010–2020) , 2010, Critical reviews in toxicology.
[38] Jerzy Leszczynski,et al. Advantages and limitations of classic and 3D QSAR approaches in nano-QSAR studies based on biological activity of fullerene derivatives , 2016, Journal of Nanoparticle Research.
[39] Alessandro Pedretti,et al. Assessing drug-likeness--what are we missing? , 2008, Drug discovery today.
[40] Menachem Elimelech,et al. Microbial cytotoxicity of carbon-based nanomaterials: implications for river water and wastewater effluent. , 2009, Environmental science & technology.
[41] Vicki Stone,et al. Review of fullerene toxicity and exposure--appraisal of a human health risk assessment, based on open literature. , 2010, Regulatory toxicology and pharmacology : RTP.
[42] Fred Wudl,et al. Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification , 1993 .
[43] M. V. Velzen,et al. Self-organizing maps , 2007 .
[44] E. W. Godly,et al. Nomenclature and terminology of fullerenes: A preliminary study , 1997 .
[45] G. P. Moss,et al. Nomenclature for the C60-Ih and C70-D5h(6) fullerenes (IUPAC Recommendations 2002) , 2002 .
[46] Johann Gasteiger,et al. Neural networks in chemistry and drug design , 1999 .
[47] Hao Zhang,et al. Structural Basis of Fullerene Derivatives as Novel Potent Inhibitors of Protein Tyrosine Phosphatase 1B: Insight into the Inhibitory Mechanism through Molecular Modeling Studies , 2016, J. Chem. Inf. Model..
[48] Matthias Rainer,et al. Medicinal applications of fullerenes , 2007, International journal of nanomedicine.
[49] Alison Elder,et al. Correlating physico-chemical with toxicological properties of nanoparticles: the present and the future. , 2010, ACS nano.
[50] Arnout Ceulemans,et al. Electron Deficiency of the Fullerenes , 1995 .
[51] David S. Goodsell,et al. RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy , 2018, Nucleic Acids Res..
[52] Dana Martin and Mati Karelson. The Quantitative Structure Activity Relationships for Predicting HIV Protease Inhibition by Substituted Fullerenes , 2010 .
[53] James W. Arbogast,et al. Electron transfer to triplet fullerene C60 , 1992 .
[54] Jerzy Leszczynski,et al. Nanomaterials – the Next Great Challenge for Qsar Modelers , 2009, Recent Advances in QSAR Studies.
[55] Serdar Durdagi,et al. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations. , 2008, Bioorganic & medicinal chemistry.
[56] Jure Zupan,et al. Kohonen and counterpropagation artificial neural networks in analytical chemistry , 1997 .
[57] Emilio Benfenati,et al. SMILES in QSPR/QSAR Modeling: results and perspectives. , 2007, Current drug discovery technologies.
[58] Andrew P. Worth. The Future of In Silico Chemical Safety … and Beyond , 2019 .
[59] Li Xiao,et al. The water-soluble fullerene derivative "Radical Sponge" exerts cytoprotective action against UVA irradiation but not visible-light-catalyzed cytotoxicity in human skin keratinocytes. , 2006, Bioorganic & medicinal chemistry letters.
[60] M. Somani. Fullerenes: Chemistry and Its Applications , 2015 .
[61] Bradley C Doak,et al. Cell permeability beyond the rule of 5. , 2016, Advanced drug delivery reviews.
[62] Stephen Mann,et al. Nanoparticles can cause DNA damage across a cellular barrier. , 2009, Nature nanotechnology.
[63] Ahmad Irfan,et al. Quantum chemical design of nonlinear optical materials by sp2-hybridized carbon nanomaterials: issues and opportunities , 2013 .
[64] Michael D Shultz,et al. Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs. , 2018, Journal of medicinal chemistry.